Clicky

Quanterix Corporation(QTRX)

Description: Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.


Keywords: Biotechnology Life Sciences Biology Disease Infectious Diseases Inflammation Biomarkers Cardiology Urology Neurology Quality Of Life Digital Health Digital Health Solution

Home Page: www.quanterix.com

QTRX Technical Analysis

Building 1
Billerica, MA 01821
United States
Phone: 617 301 9400


Officers

Name Title
Dr. Masoud Toloue Ph.D. Pres, CEO & Director
Dr. David R. Walt Ph.D. Co-Founder, Chairman of Scientific Advisory Board & Independent Director
Mr. Michael A. Doyle CFO & Treasurer
Mr. Bruce J. Bal VP of Operations, Service & Quality
Mr. Daniel Pikora Chief Operating Officer
Dr. David C. Duffy Ph.D. Sr. VP of R&D and CTO
David Panzerella VP of Sales
Dr. Mark T. Roskey Ph.D. Sr. VP of Strategic Partnerships
Ms. Mary Ellen Cortizas VP of Laboratory Services & CRO

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.2923
Price-to-Sales TTM: 4.4708
IPO Date: 2017-12-07
Fiscal Year End: December
Full Time Employees: 460
Back to stocks